MALAT1 and Hepatic fibrosis: ROC analysis of the plasma EVs-Lnc-MALAT1 levels in 60 cases of liver fibrosis patients and 46 control subjects in our current study revealed 65.6% of AUC, with 51.7% of sensitivity and 78.3% of specificity.